Nigeria’s Health Financing: Rethinking Health Insurance, Donor Transition, and the Path to Universal Health Coverage

Mello Health Strategy Group operates with a distinct global orientation, recognizing that modern population health challenges cannot be solved in isolation. Our work is informed by the political, economic, institutional, and social ecosystems that shape health delivery across different settings. By integrating competencies across health systems strengthening, implementation science, program evaluation, and health strategy, Mello seeks to translate evidence into measurable outcomes. This orientation is also reflected in our collaborations with nonprofit and nongovernmental organizations, including CMG Global Foundation. Our underlying philosophy is straightforward: sustainable health transformation occurs when strategy, science, financing, implementation, measurement, and organizational learning function as an interconnected system.

This framework directly addresses Nigeria's current health financing inflection point. For decades, the nation's health system has relied on a fragmented matrix of public allocations, out-of-pocket household expenditures, health insurance pools, private capital, and international development assistance. Because these funding streams operate in isolation, the architecture remains deeply fragmented, exposing citizens to severe financial hardships. Compounding this challenge is the structural transformation of the international development ecosystem. With global aid priorities shifting under escalating fiscal pressures, the international development ecosystem is rapidly pivoting toward domestic resource mobilization, institutional co-financing, and self-sustaining local ownership. This fiscal reality demands that the strategic lens for Nigerian policymakers evolve. Progress can no longer be measured simply by expanding raw insurance coverage or managing donor exit; instead, Nigeria must pioneer a resilient health financing ecosystem engineered to capture, optimize, and translate all available domestic and international capital into equitable, high-value health outcomes.

The scale of the challenge remains substantial. Recent health financing assessments indicate that approximately seven out of every ten naira spent on healthcare in Nigeria comes directly from households through out-of-pocket payments. In July 2026, the Federal Ministry of Health and Social Welfare reported that out-of-pocket expenditure remained approximately 71 percent of total health spending. Such dependence on household expenditure means that illness becomes both a clinical and an economic event. Families may delay treatment, forego care, borrow money, sell assets, or divert resources from food, education, housing, and other essential needs to finance healthcare.

Financial protection is not a secondary feature of Universal Health Coverage (UHC); it is one of its defining characteristics. Nigeria has nevertheless made important progress in constructing the institutional foundations for reform. The National Health Insurance Authority (NHIA) Act of 2022 strengthened the legal basis for expanding health insurance, while the Basic Health Care Provision Fund (BHCPF) provides an important mechanism for financing essential health services, particularly for poor and vulnerable populations. State health insurance agencies have expanded, and health insurance enrollment has grown substantially. By July 2026, the Federal Ministry of Health and Social Welfare reported that more than 22 million Nigerians had been enrolled in health insurance. The government has also reported substantial investment through the BHCPF, including more than ₦339 billion disbursed over the life of the program.

Recent advancements in Nigeria's healthcare landscape highlight a critical policy paradox: a surge in formal insurance enrollment does not automatically yield a decline in extraordinarily high out-of-pocket expenditures. This disconnect serves as a stark warning to policymakers against equating raw registration metrics with the realization of Universal Health Coverage (UHC). Possessing an insurance card is merely an administrative step; it is not a guarantee of timely, affordable, or high-quality care. Health coverage only becomes meaningful when enrollment actively translates into robust provider networks, reliable access to essential medicines and diagnostics, financial risk protection, and ultimately, superior health outcomes.

This distinction becomes clearer when Nigeria’s health financing challenge is considered through established health policy frameworks. John Kingdon’s Multiple Streams Framework provides a useful starting point. Kingdon argues that significant policy change becomes possible when three streams converge: recognition of a problem, availability of feasible policy solutions, and a political environment receptive to change. Nigeria increasingly appears to have the ingredients of such a policy window.

The problem stream is evident in high out-of-pocket expenditure, financial hardship, unequal access to healthcare, fragmented financing, and continued reliance on international assistance for important health programs. The policy stream includes the NHIA, BHCPF, state health insurance schemes, primary healthcare reforms, and the Nigeria Health Sector Renewal Investment Initiative. The political stream is reflected in renewed national attention to UHC, domestic resource mobilization, health-sector reform, and greater alignment between government and development partners. The convergence of these streams creates an opportunity for significant reform. However, opening a policy window does not guarantee successful implementation. Political attention may initiate reform; institutions must sustain it.

The World Health Organization’s approach to health financing provides another useful lens. Health financing can broadly be understood through three interrelated functions: revenue raising, pooling, and purchasing. Examining Nigeria through these functions shifts the discussion beyond simply asking whether enough money is being spent. Revenue raising concerns where healthcare resources originate. Nigeria’s financing mix includes federal and state government revenues, household contributions, employer contributions, insurance premiums, private-sector resources, and international development assistance. The policy challenge is not simply to raise more money, but to increase the share of financing that is predictable, prepaid, and progressive, rather than collected from individuals when they become sick.

At its core, risk pooling dictates how financial risk is shared across a society. Highly effective pooling structures allow healthy populations to cross-subsidize those who become ill, while broader public financing mechanisms ensure that citizens with greater economic capacity protect those with fewer resources. Fragmented financing arrangements systematically weaken this redistributive principle. To overcome this, Nigeria must continuously consolidate larger, more equitable risk pools while ensuring that poor and vulnerable populations are fully subsidized rather than structurally excluded due to premium costs.

Strategic purchasing addresses a critical, yet frequently underappreciated inquiry: what explicit value does Nigeria receive for the money it spends? Health insurance institutions must evolve beyond the passive role of collecting contributions and reimbursing claims; they must become strategic purchasers capable of leveraging financial resources to directly influence clinical quality, provider efficiency, disease prevention, and health equity. In this context, provider payment incentives are paramount. Mechanisms, such as capitation, fee-for-service, case-based payments, and performance incentives, each drive vastly different behaviors. The core challenge lies in designing purchasing frameworks that actively reward high-quality care and measurable health outcomes. Consequently, Nigeria’s health financing paradigm must shift from tracking total expenditure to measuring the value produced by every naira spent.

This systemic shift toward value creates a direct bridge to the Quadruple Aim. Expanding upon the traditional Triple Aim, the Quadruple Aim framework optimizes population health, elevates the patient care experience, enhances affordability, and supports the healthcare workforce. Applied to Nigeria, this model offers a distinct, outcomes-oriented blueprint for financing reform. Improving population health requires that funding decisions align with Nigeria’s true epidemiological burden and community needs rather than historical spending inertia. Improving the experience of care recognizes that insurance yields negligible benefits if patients encounter stockouts of essential medicines, inaccessible facilities, fragmented referral pathways, or unexpected out-of-pocket payments. Finally, optimizing value mitigates financial catastrophe for families, while supporting the workforce ensures that insurance does not attempt to purchase services that the frontline system lacks the human capital to deliver.

The Quadruple Aim serves as the definitive bridge connecting financial mechanisms directly to system-level outcomes. While revenue mobilization dictates where resources originate, pooling governs how financial risk is distributed, and strategic purchasing determines what those resources ultimately buy. The Quadruple Aim provides the objective scorecard to evaluate whether these complex financial choices yield meaningful real-world progress. Consequently, health system success must not be judged by isolated spending metrics or raw enrollment numbers, but by whether financing actively improves population health, elevates the patient experience, guarantees affordability, and strengthens the capacity of the frontline workforce.

This leads to another important distinction: health insurance coverage does not automatically produce healthcare access. Andersen’s Behavioral Model of Health Services Use can serve as a theoretical underpinning for understanding this gap. Andersen’s model recognizes that healthcare utilization is influenced by predisposing characteristics, enabling resources, and healthcare needs. Insurance is an important enabling resource, but insurance alone cannot overcome every barrier. A Nigerian may technically be insured and still lack meaningful access because the nearest participating facility is too distant, medicines are unavailable, transportation is unaffordable, diagnostic capacity is limited, providers are insufficient, waiting times are excessive, or the perceived quality of care is poor. Consequently, measuring progress primarily by the number of people enrolled risks confusing administrative coverage with effective coverage.

Nigeria’s health policy must prioritize systemic depth over raw insurance numbers. True equity means tracking who remains outside the system and ensuring rural and low-income communities have equal access. It means confirming that insured patients can receive care, obtain medicines, and utilize diagnostic networks. Most importantly, it means ensuring that insurance successfully shields households from financial ruin.

Sustainable health financing requires a comprehensive implementation strategy. Reforms must align with the local context and the system's actual delivery capacity. Coverage is only valuable when it translates into real access and optimized expenditure. To ensure long-term sustainability, institutions must use performance data to adapt continuously, anchoring health gains far beyond temporary funding cycles.

This is where the future role of donor organizations becomes particularly important. International development partners have made indispensable contributions to health in Nigeria. The Global Fund to Fight AIDS, Tuberculosis and Malaria; Gavi, the Vaccine Alliance; the World Bank; the World Health Organization; the United States Government; and other bilateral and multilateral partners have supported immunization, human immunodeficiency virus programs, tuberculosis and malaria control, maternal and child health, laboratories, disease surveillance, emergency preparedness, workforce development, commodities, and health-system strengthening. The appropriate question is not whether donor organizations have been valuable. Their contributions are substantial. The more consequential question is how the relationship should evolve as Nigeria develops stronger domestic institutions.

The next generation of development assistance should increasingly function as catalytic financing. External resources can be strategically deployed to strengthen the systems that eventually allow Nigeria to sustain health gains with progressively greater domestic ownership. This represents an evolution from donors primarily financing programs toward donors increasingly helping countries develop the institutional capacity to finance, purchase, implement, evaluate, and sustain those programs themselves. The transition should not mean abrupt donor withdrawal. Nigeria continues to face substantial population health needs, and poorly managed financing transitions could reverse hard-won gains. The objective should instead be donor-enabled sustainability rather than donor dependence or donor disengagement.

The Reach, Effectiveness, Adoption, Implementation, and Maintenance framework, commonly known as RE-AIM, offers a useful way of thinking about this transition. Although originally developed to improve the translation of research into sustainable real-world interventions, its principles are highly relevant to donor-supported health programs. Reach asks whether programs reach populations most in need. Effectiveness asks whether they produce meaningful health outcomes. Adoption examines whether Nigerian institutions, healthcare organizations, and providers take ownership of interventions. Implementation considers whether programs are delivered consistently and effectively under real-world conditions. Maintenance asks perhaps the most consequential question for donor-supported programs: can the intervention and its benefits continue after external financing decreases?

Seen through this lens, sustainability should not begin when a donor announces its exit. Sustainability should be designed into programs from their inception. This leads to an important value proposition: the success of donor investment should be measured not only by what it achieves while external financing is present, but also by the country’s ability to sustain those gains as external financing declines.

Major donor-supported initiatives should contain credible pathways for domestic co-financing, workforce transfer, procurement continuity, data ownership, institutionalization, governance, and long-term evaluation. Development assistance could support the underlying infrastructure required for sustainable health financing: actuarial capacity, beneficiary identification, digital enrollment, claims management, provider accreditation, quality measurement, fraud detection, health technology assessment, strategic purchasing, workforce development, supply chains, surveillance, implementation research, and health information systems.

These investments may be less visible than constructing a facility or financing a stand-alone disease program, but they build something potentially more enduring: institutional capability. Nigeria’s relationship with its development partners is already evolving in this direction. The Global Fund increasingly emphasizes sustainability, transition planning, domestic resource mobilization, co-financing, and alignment with national systems. Nigeria itself now occupies both sides of the global-health financing relationship, contributing resources to the Global Fund while remaining an important implementer of Global Fund-supported programs. This evolution from recipient alone toward recipient, contributor, and partner represents an important shift in the global-health financing relationship.

The relationship between donor-supported vertical programs and Nigeria’s broader health system must also evolve carefully. Programs addressing human immunodeficiency virus, tuberculosis, malaria, immunization, and other priorities have achieved important gains partly because dedicated resources, technical expertise, procurement systems, and accountability mechanisms were concentrated around clearly defined objectives. Integration should not mean dismantling systems that work. Instead, Nigeria should identify which functions can progressively migrate into domestic financing, insurance, procurement, information, workforce, and service-delivery systems while preserving the technical capabilities responsible for successful outcomes.

Health insurance can play an important role in this transition, but not every public-health function belongs within an insurance benefit package. Individual preventive, diagnostic, and therapeutic services may appropriately be purchased through insurance pools. Disease surveillance, outbreak investigation, emergency preparedness, reference laboratories, health promotion, and other public goods require predictable public financing. A mature health financing architecture must distinguish between financing healthcare for individuals and financing public health for populations.

Nigeria’s large informal economy further complicates the financing equation. A health-insurance system built predominantly around payroll contributions cannot easily achieve universality when a substantial proportion of the population earns income outside formal employment. Nigeria consequently requires a mixed financing model involving general taxation, federal and state resources, formal-sector contributions, employer financing, the BHCPF, private-sector participation, and strategically deployed development assistance.

However, Nigeria’s search for diversified health financing should not end with taxation, insurance contributions, and donor grants. Another opportunity deserving serious policy consideration is the strategic use of capital markets to mobilize long-term investment for health-system capacity. The distinction here is important. This should not mean exposing individual health insurance benefits or resources required for routine healthcare claims to inappropriate financial-market risk. Rather, Nigeria could develop a clearer relationship between health financing and capital formation by using appropriately regulated financial instruments to mobilize investment for the infrastructure, technology, and institutional capacity required to make health insurance effective.

There is already a foundation for such thinking. Nigeria has considered innovative health-financing mechanisms, including proposals for a Diaspora Health Investment Bond, while the Federal Government has increasingly called for greater collaboration among government, financial institutions, development finance institutions, and private investors to finance healthcare infrastructure, diagnostics, pharmaceutical manufacturing, primary healthcare, and other health-sector priorities. These developments suggest that the relationship between health financing and investment markets deserves greater attention.

To unlock alternative funding streams, Nigeria can leverage structured health infrastructure bonds, diaspora health bonds, and blended finance vehicles to attract private and institutional capital into health system development. These alternative mechanisms are uniquely positioned to fund capital-intensive, long-term assets that traditional government budgets and donor grants fail to scale. This includes critical investments in primary healthcare infrastructure, diagnostic and laboratory networks, digital health ecosystems, clean healthcare electrification, and localized pharmaceutical manufacturing. Operationalizing this strategy requires a strict conceptual distinction between financing healthcare consumption versus healthcare capacity. While health insurance pools risk to create purchasing power for immediate services, capital markets provide the long-term investment capital required to build the underlying infrastructure from which those very services are delivered.

Properly structured, the two mechanisms can reinforce one another. Insurance creates predictable healthcare demand and purchasing capacity. Investment capital expands supply-side capacity. Stronger capacity makes insurance coverage more meaningful. Strategic purchasing can generate more predictable revenue for high-performing providers, while improved institutional performance can strengthen investor confidence and potentially attract additional capital.

The objective, however, should not be the financialization of healthcare for its own sake. Capital should be mobilized toward measurable public health value. Here again, the Quadruple Aim provides a useful safeguard. A hospital bond, diagnostic investment, digital health platform, pharmaceutical facility, or primary care infrastructure project should not be judged solely by its financial return. Policymakers should also ask whether the investment improves population health, patient experience, affordability and efficiency, health equity, and workforce capacity.

This creates another potential role for development partners. Rather than financing every intervention indefinitely, donors and development finance institutions could increasingly use grants, concessional capital, guarantees, technical assistance, outcome-linked financing, and other risk-sharing mechanisms to make strategically important health investments more attractive to domestic and international investors. Properly governed blended-finance arrangements could allow limited public and donor resources to catalyze larger pools of investment capital while maintaining public-health objectives.

Therefore, donor transition need not mean replacing every donor dollar with a government naira on a one-for-one basis. A more sophisticated transition could involve using public and development resources strategically to mobilize additional domestic and private capital while protecting equity, access, and financial protection. Government provides stewardship and public financing; insurance creates pooled purchasing power; appropriately regulated capital markets can finance selected long-term health-system capacity; healthcare organizations provide services; and development partners can help reduce risk and strengthen institutions.

Equity must remain central to this architecture. Poor and vulnerable Nigerians cannot reasonably be expected to finance UHC through premiums they cannot afford, nor should access to essential healthcare depend on the performance of financial markets. Government subsidies for vulnerable populations are not charitable additions to health insurance; they are fundamental components of equitable risk pooling. Capital market participation should complement these public responsibilities, not replace them.

This is where health insurance becomes population health policy. It is also where health financing can become part of a broader national investment strategy. The challenge is no longer simply to determine who pays for healthcare, but how public resources, pooled insurance funds, private investment, development finance, and donor resources can perform different, but complementary functions within a coherent health financing architecture.

Nigeria’s Sector-Wide Approach provides an important opportunity to bring many of these principles together. Aligning government and development partners around common priorities, financing strategies, monitoring systems, and accountability structures offers an alternative to fragmented financing and parallel programming. If implemented effectively, such alignment can create a platform through which domestic and international resources increasingly support national priorities rather than separate institutional agendas.

This discussion also has important implications for global health security. UHC and global health security are frequently treated as separate policy agendas, yet they depend on many of the same underlying systems. A functioning primary healthcare network provides an entry point for vaccination, surveillance, early diagnosis, referral, health education, and outbreak detection. A financially protected population may be more able to seek care before illness becomes severe. Laboratories, healthcare workers, supply chains, information systems, financing mechanisms, and trusted institutions serve routine healthcare but become indispensable during emergencies.

Health financing should be viewed as part of national health-security infrastructure. The policy opportunity before Nigeria can ultimately be understood through the convergence of several complementary frameworks. Kingdon helps explain when reform becomes politically feasible. The World Health Organization’s financing functions explain how resources can be raised, pooled, and strategically purchased. The Quadruple Aim asks whether financing produces the outcomes that matter. Andersen reminds us that financial coverage does not automatically produce meaningful access. RE-AIM helps determine whether programs reach populations, produce results, become institutionalized, and survive over time.

Rather than relying on isolated interventions, these insights form a coherent framework to align insurance scaling, external aid, and domestic capital into a sustainable whole. This approach shifts the traditional dynamics between Nigeria and international development partners, moving past zero-sum debates between government and private funding, or capital markets and public investment. The core structural challenge is to orchestrate a system where these distinct levers work in absolute synergy. Achieving this harmony requires a clear redistribution of institutional roles: the public sector must escalate predictable domestic revenues to shield vulnerable citizens; insurance regulators must evolve into market-shaping strategic purchasers; and delivery networks must take ownership of care safety and efficiency. Concurrently, private enterprise and capital markets must co-invest to expand long-term productive capacity, civil society must provide vital feedback loops to keep services centered on population needs, and international donors must act strictly as catalytic technical partners dedicated to institutional capacity building. This approach shifts the goalpost from donor withdrawal to long-term operational sustainability and asks a fundamental question: how do we turn every available naira, donor dollar, and mobilized investment into equitable, sustainable population health outcomes?

Nigeria’s future should be defined neither by indefinite donor dependence nor by an unrealistic expectation of immediate financial self-sufficiency. It must be shaped by a deliberate transition toward a resilient health system in which domestic resources progressively increase, financial risks are pooled more equitably, and evidence continuously informs strategic spending. At Mello Health Strategy Group, we believe sustainable transformation occurs at the intersection of strategy, science, execution, and organizational learning. Applying this framework to Nigeria means building a continuous loop that ties financing directly to execution, execution to real outcomes, and outcomes to the institutional insights needed to guide future investments. This transition shifts the paradigm from financing isolated programs to building enduring national institutions, and from tracking input expenditures to buying real value. This is how Universal Health Coverage achieves its true utility: not when citizens acquire insurance cards, but when every individual can access essential health services without sacrificing their economic security.

About the Author: Olu Albert is the Founder and Principal Consultant of Mello Health Strategy Group, a consulting firm specializing in health care strategy and population health solutions.

Mello Health Strategy Group

• Expertise in epidemiology and population health

• Experience in health systems operations and program oversight

• Ability to translate research into practical health system solutions.

© 2026. All rights reserved.

Hours of Operation

M - F: 8:30am - 5pm
Weekends: Closed

Office

35 Katherine Dr.
Burlington, NJ 08016

Contact

E: contact@mellohealthstrategy.com
P: (609) 227-7970

Business Information

• UEI: GCNTP6Y7MMT1

• NAICS Codes: 541690, 541611, 611430

• Business Type: Small Business MBE/VOSB/SBE/VOB/Economically disadvantaged

• SAM.gov Registered